OneSource Specialty Pharma LimitedOneSource Specialty Pharma LimitedOneSource Specialty Pharma Limited

OneSource Specialty Pharma Limited

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪211.31 B‬INR
−7.15INR
‪−179.71 M‬INR
‪14.45 B‬INR
‪64.40 M‬
Beta (1Y)
1.32
Employees (FY)
‪1.77 K‬
Change (1Y)
‪+1.25 K‬ +237.71%
Revenue / Employee (1Y)
‪8.15 M‬INR
Net income / Employee (1Y)
‪−97.47 K‬INR

About OneSource Specialty Pharma Limited


CEO
Neeraj Sharma
Headquarters
Bengaluru
Founded
2007
ISIN
INE013P01021
FIGI
BBG01RXVLCG7
OneSource Specialty Pharma Ltd. operates as a a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally. It provides end-to-end CDMO services across various phases of preclinical and clinical development and commercial supply of biologics. The company was founded by Arun Kumar on June 12, 2007 and is headquartered in Bangalore, India.

Check out other big names from the same industry as ONESOURCE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
VSS
Vanguard FTSE All-World ex-US Small-Cap ETF
Weight
0.03%
Market value
‪4.21 M‬
USD
SPEM
SPDR Portfolio Emerging Markets ETF
Weight
0.02%
Market value
‪2.94 M‬
USD
SMIN
iShares MSCI India Small Cap ETF
Weight
0.23%
Market value
‪2.23 M‬
USD
HDFCSML250
HDFC Nifty Smallcap 250 ETF
Weight
0.51%
Market value
‪825.03 K‬
USD
SPYX
SPDR MSCI Emerging Markets Small Cap UCITS ETF
Weight
0.07%
Market value
‪284.08 K‬
USD
EEMS
iShares MSCI Emerging Markets Small Cap ETF
Weight
0.07%
Market value
‪267.47 K‬
USD
EUNI
iShares MSCI EM Small Cap UCITS ETF
Weight
0.06%
Market value
‪208.84 K‬
USD
GMF
SPDR S&P Emerging Asia Pacific ETF
Weight
0.04%
Market value
‪170.58 K‬
USD
AVES
Avantis Emerging Markets Value ETF
Weight
0.02%
Market value
‪164.00 K‬
USD
AVSE
Avantis Responsible Emerging Markets Equity ETF
Weight
0.03%
Market value
‪41.53 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of ONESOURCE is 1,832.70 INR — it has decreased by −0.44% in the past 24 hours. Watch OneSource Specialty Pharma Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange OneSource Specialty Pharma Limited stocks are traded under the ticker ONESOURCE.
ONESOURCE stock has fallen by −0.23% compared to the previous week, the month change is a 3.08% rise, over the last year OneSource Specialty Pharma Limited has showed a 1.82% increase.
We've gathered analysts' opinions on OneSource Specialty Pharma Limited future price: according to them, ONESOURCE price has a max estimate of 2,529.00 INR and a min estimate of 2,417.00 INR. Watch ONESOURCE chart and read a more detailed OneSource Specialty Pharma Limited stock forecast: see what analysts think of OneSource Specialty Pharma Limited and suggest that you do with its stocks.
ONESOURCE reached its all-time high on Jun 18, 2025 with the price of 2,248.00 INR, and its all-time low was 1,209.95 INR and was reached on Mar 3, 2025. View more price dynamics on ONESOURCE chart.
See other stocks reaching their highest and lowest prices.
ONESOURCE stock is 2.16% volatile and has beta coefficient of 1.32. Track OneSource Specialty Pharma Limited stock price on the chart and check out the list of the most volatile stocks — is OneSource Specialty Pharma Limited there?
Today OneSource Specialty Pharma Limited has the market capitalization of ‪211.31 B‬, it has increased by 0.01% over the last week.
Yes, you can track OneSource Specialty Pharma Limited financials in yearly and quarterly reports right on TradingView.
OneSource Specialty Pharma Limited is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
OneSource Specialty Pharma Limited revenue for the last quarter amounts to ‪3.27 B‬ INR, despite the estimated figure of ‪3.95 B‬ INR. In the next quarter, revenue is expected to reach ‪3.62 B‬ INR.
ONESOURCE net income for the last quarter is ‪−1.86 M‬ INR, while the quarter before that showed ‪985.02 M‬ INR of net income which accounts for −100.19% change. Track more OneSource Specialty Pharma Limited financial stats to get the full picture.
No, ONESOURCE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 25, 2025, the company has ‪1.77 K‬ employees. See our rating of the largest employees — is OneSource Specialty Pharma Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OneSource Specialty Pharma Limited EBITDA is ‪4.14 B‬ INR, and current EBITDA margin is 32.16%. See more stats in OneSource Specialty Pharma Limited financial statements.
Like other stocks, ONESOURCE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OneSource Specialty Pharma Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OneSource Specialty Pharma Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OneSource Specialty Pharma Limited stock shows the strong buy signal. See more of OneSource Specialty Pharma Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.